发明申请
US20140309279A1 GAPPED OLIGOMERIC COMPOUNDS COMPRISING 5'-MODIFIED DEOXYRIBONUCLEOSIDES IN THE GAP AND USES THEREOF
有权
包含5'修饰的脱氧核糖核苷酸的GAPPED低分子化合物及其用途
- 专利标题: GAPPED OLIGOMERIC COMPOUNDS COMPRISING 5'-MODIFIED DEOXYRIBONUCLEOSIDES IN THE GAP AND USES THEREOF
- 专利标题(中): 包含5'修饰的脱氧核糖核苷酸的GAPPED低分子化合物及其用途
-
申请号: US14238094申请日: 2012-08-08
-
公开(公告)号: US20140309279A1公开(公告)日: 2014-10-16
- 发明人: Michael Oestergaard , Thazha P. Prakash , Punit P. Seth , Eric E. Swayze
- 申请人: Michael Oestergaard , Thazha P. Prakash , Punit P. Seth , Eric E. Swayze
- 申请人地址: US CA Carlsbad
- 专利权人: ISIS PHARMACEUTICALS, INC.
- 当前专利权人: ISIS PHARMACEUTICALS, INC.
- 当前专利权人地址: US CA Carlsbad
- 国际申请: PCT/US12/49989 WO 20120808
- 主分类号: C12N15/113
- IPC分类号: C12N15/113
摘要:
The present invention provides gapped oligomeric compounds comprising at least one 5′-substituted P-D-2′-deoxyribonucleoside in the gap region. Certain such gapped oligomeric compounds are useful for hybridizing to a complementary nucleic acid, including but not limited to, nucleic acids in a cell. The oligomeric compounds provided herein have improved properties such as selectivity, potency and improved proinflammatory profile. In certain embodiments, hybridization results in modulation of the amount of activity or expression of the target nucleic acid in a cell.
公开/授权文献
信息查询
IPC分类: